Angiotensin-II-receptor antagonists are well tolerated and are as effective as ACE inhibitors in decreasing blood pressure. Currently, AT-II-receptor antagonists are used either as monotherapy in patients who cannot tolerate ACE inhibitors or in combination with hydrochlorothiazide or other antihypertensive agents.
[a] Valsartan data on file. Novartis, East Hanover, NJ; 1996.
[b] Chando TJ, Everett DW, Kahle AD et al. Biotransformation of irbesartan in man. Data on file. Bristol-Myers Squibb, Princeton, NJ; 1997.
[c] Telmisartan data on file. Boehringer Ingelheim, Ridgefield, CT; 1998.
Address reprint requests to Ms. Dina at 680 Mira Monte Place, Pasadena, CA 91101, or to email@example.com.
Am J Health Syst Pharm. 2000;57(13) © 2000 American Society of Health-System Pharmacists
Cite this: Angiotensin II-Receptor Antagonists: An Overview - Medscape - Jul 01, 2000.